IMS Health purchased for $5.2 billion

IMS Health will be acquired by TPG Capital and the Canadian Pension Plan Investment Board, an investment management organization, for $5.2 billion.

The acquisition also covers IMS Health's outstanding debt, equaling roughly $1.3 billion as of September 30, according to third quarter reports.

A spokesperson for IMS Health said the company will continue operating under its flagship name—IMS Health. There are no immediate plans to change senior management, the spokesperson said. IMS Health “will continue our focus on expanding into new markets, further improving the quality and depth of offerings we deliver to our clients and playing a bigger role in the healthcare market,” David Carlucci, IMS chairman and CEO, said in a statement. The acquisition is expected to be completed by the end of the first quarter, 2010.

IMS Health's third quarter revenue was $540.8 million—down from $573.7 during the same period last year.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.